Tuomas Rosberg, MD, PhD

Department of Respiratory Medicine, Kanta-Hame Central Hospital, Hameenlinna , Finland, Finland

Disclosure(s): AstraZeneca: Honoraria; Boehringer-Ingelheim: Honoraria; GSK: Honoraria

Poster(s):

• 1126 - Effect of Remdesivir on Recovery, Quality of Life, and Long-COVID Symptoms One Year after Hospitalization for COVID-19 Infection: A Randomized Controlled SOLIDARITY Finland Trial
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET